Rotator Cuff Repair Innovation

Ending the Era of Failed Repairs

Reinforcing what matters most — the suture-tendon interface. TENOGARDE™ is a novel bio-absorbable eyelet implant that eliminates the root cause of rotator cuff repair failure.

TENOGARDE™ eyelet implant — front view TENOGARDE™ eyelet implant — side profile TENOGARDE™ eyelet implant — perspective view TENOGARDE™ eyelet implant — rear view

TENOGARDE™ Eyelet Implant

The Weakest Link in
Rotator Cuff Surgery

Even with advancement in techniques and suture anchors, rotator cuff repair still fails too often. The problem is often the suture cutting through weakened tendon tissue.

01

The Cheese-Wiring Effect

Animated demonstration of cheese-wiring effect — suture cutting through tendon tissue under tension

High-tension sutures cut through degenerative tendon tissue like wire through cheese, causing the repair to fail.

02

Most Frequent Failure Mode

Close-up of suture pulling through tendon tissue at the suture-tendon interface

The suture-tendon interface is the weakest point in the entire repair construct — yet current solutions don't address it.

03

The Revision Burden

60% Re-tear rate WITHIN 2 YEARS OF SURGERY Intact Failed

Up to 60% of rotator cuff repairs fail within 2 years, requiring costly revision surgery with worse outcomes.

A Smarter Point
of Fixation

TENOGARDE™ is a novel bio-absorbable eyelet implant that fundamentally changes how sutures interact with tendon tissue.

  • 01

    Ease of Delivery

    Eyelet implant delivered through custom-designed arthroscopic instrumentation for seamless surgical integration.

  • 02

    Reinforcing the Suture-Tendon Junction

    Built to protect where repairs fail most. TenoGarde buffers the suture-tendon junction, distributes load across three contact points, and activates under tension — reinforcing the repair from the moment it matters.

  • 03

    Bio-absorbable Implant

    Strength retention of minimum 3 months matching the critical healing period for rotator repair.

*Tenogarde is under development and is not authorized to be marketed or sold in any market.

TENOGARDE™ eyelet implant in situ — surgical view

Performance Data &
Versatile Applications

TENOGARDE™ delivers measurable improvements in repair strength across multiple suture configurations.

Single Row Repair with TENOGARDE™

Single Row Repair

Knotless Double Row with TENOGARDE™

Knotless Double Row

Suture Bridge with TENOGARDE™

Suture Bridge

Cadaveric Trials
3
Animal Evaluations
JLAB QuickFire Award
3
Patent Families

Designed for Surgeons

An experienced execution team and board with deep expertise in orthopedics, medical devices, and clinical translation.

Ryan Kua

Ryan Kua

CEO
More than ten years of experience in research and development.
LinkedIn
Dr James Tan

Dr James Tan, MD

Clinical Advisor
Medical Director. Quantum Orthopaedics, Mount Elizabeth Medical.
LinkedIn
Alan Horner

Alan Horner, PhD

Scientific Advisor
Previously Head Translation Science at Convatec, Scientific Director at Smith+Nephew, CTO at Gelmetix.
LinkedIn

Board of Directors

Andy Weymann

Andy Weymann, MD MBA

Chairman of the Board
Orthopedics Surgeon. Previously Chief Medical Officer and Senior Vice President at Smith+Nephew.
LinkedIn
Todd Dollinger

Todd Dollinger

Board Member
Founder & Chair Emeritus, The Trendlines Group, Ltd.
LinkedIn
Eric Loh

Eric Loh

Board Member
Founding CEO, Trendlines Medical Singapore. Previously Senior Vice President, Biosensors International Ltd.
LinkedIn
Meinrad Lugan

Meinrad Lugan, PhD

Board Member
BVMed Honorary Chairman, Medtech Europe board member. Previously CEO of B.Braun Hospital Care and OPM Division.
LinkedIn

Let's Talk

Whether you're a surgeon interested in clinical collaboration, or an investor exploring opportunities in orthopedic innovation — we'd love to hear from you.

Office
1 Pasir Panjang Rd, Labrador Tower
Singapore 118479
Send us a message

We typically respond within 1–2 business days.